주식/증권
➡️ 중립
3 Healthcare Stocks We Steer Clear Of
요약
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 5.8% return has trailed the S&P 500 by 1.9 percentage points.